CHMP Recommends Novo's (NVO) Refixia for Approval in Hemophilia B

Source Link:

https://globenewswire.com/news-release/2017/03/24/943924/0/en/Novo-Nordisk-receives-positive-opinion-from-the-European-regulatory-authorities-for-Refixia-nonacog-beta-pegol-N9-GP-for-the-treatment-of-haemophilia-B.html